InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
3
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-31.3%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the detailed record of transactions filed by Belldegrun Arie, 董事. Insider active across 6 companies, notably Allogene Therapeutics, Inc.. Cumulatively, 16 filings have been published. Split: 3 buys · 0 sell. Total volume traded: €1.7m. Activity tracked since 24 May 2021. The latest transaction was filed on 20 June 2025 (U). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Belldegrun Arie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
2,765,314 股@ US$0.57100.0% 占其流量Common StockSEC:0001415889-25-017834:0
369,957 股0Common StockSEC:0001737287-25-000005:0
105,263 股Class A Common StockSEC:0001127602-24-018717:0
344,828 股@ US$2.9011.1% 占其流量Common StockSEC:0001737287-24-000042:0
211,973 股0Common StockSEC:0001593968-24-000194:0
1,282,976 股0Common StockSEC:0001593968-23-000523:0
160,000 股@ US$5.0094.8% 占其流量Ordinary SharesSEC:0001437749-22-022616:0
3,241 股@ US$5.001.9% 占其流量Ordinary SharesSEC:0001437749-22-021777:0
70,921 股0Class A Common StockSEC:0000899243-22-022286:0
4,710,120 股0Common StockSEC:0001214659-22-004729:0
4,710,121 股0Common StockSEC:0001214659-22-004613:0
155,039 股@ US$12.6020.7% 占其流量Common StockSEC:0001214659-22-000701:0
标准退出：2022年4月12日 (T+90)
3,241 股@ US$5.001.7% 占其流量Ordinary SharesSEC:0001209191-21-039138:0
379,066 股@ US$18.2268.2% 占其流量Common StockSEC:0001214659-21-005878:0
1,448,062 股Common StockSEC:0000914190-16-000517:0
标准退出：2016年4月11日 (T+90)
714,285 股Common StockSEC:0000914190-16-000517:1
标准退出：2016年4月11日 (T+90)
16 条申报中的 16 条
About Belldegrun Arie
Belldegrun Arie is Administrateur and has filed 16 disclosures in total. In the sampled recent filings, they cover the period from 2016-01-14 to 2025-06-20, with EUR 1718643 of buys and EUR 0 of sells, and the stated transaction nature is Attribution.
